Literature DB >> 9109651

Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.

N Narayana1, S Cox, S Shaltiel, S S Taylor, N Xuong.   

Abstract

The crystal structure of the hexahistidine-tagged mouse recombinant catalytic subunit (H6-rC) of cAMP-dependent protein kinase (cAPK), complexed with a 20-residue peptide inhibitor from the heat-stable protein kinase inhibitor PKI(5-24) and adenosine, was determined at 2.2 A resolution. Novel crystallization conditions were required to grow the ternary complex crystals. The structure was refined to a final crystallographic R-factor of 18.2% with good stereochemical parameters. The "active" enzyme adopts a "closed" conformation as found in rC:PKI(5-24) [Knighton et al. (1991a,b) Science 253, 407-414, 414-420] and packs in a similar manner with the peptide providing a major contact surface. This structure clearly defines the subsites of the unique nucleotide binding site found in the protein kinase family. The adenosine occupies a mostly hydrophobic pocket at the base of the cleft between the two lobes and is completely buried. The missing triphosphate moiety of ATP is filled with a water molecule (Wtr 415) which replaces the gamma-phosphate of ATP. The glycine-rich loop between beta1 and beta2 helps to anchor the phosphates while the ribose ring is buried beneath beta-strand 2. Another ordered water molecule (Wtr 375) is pentacoordinated with polar atoms from adenosine, Leu 49 in beta-strand 1, Glu 127 in the linker strand between the two lobes, Tyr 330, and a third water molecule, Wtr 359. The conserved nucleotide fold can be defined as a lid comprised of beta-strand 1, the glycine-rich loop, and beta-strand 2. The adenine ring is buried beneath beta-strand 1 and the linker strand (120-127) that joins the small and large lobes. The C-terminal tail containing Tyr 330, a segment that lies outside the conserved core, covers this fold and anchors it in a closed conformation. The main-chain atoms of the flexible glycine-rich loop (residues 50-55) in the ATP binding domain have a mean B-factor of 41.4 A2. This loop is quite mobile, in striking contrast to the other conserved loops that converge at the active site cleft. The catalytic loop (residues 166-171) and the Mg2+ positioning loop (residues 184-186) are a stable part of the large lobe and have low B-factors in all structures solved to date. The stability of the glycine-rich loop is highly dependent on the ligands that occupy the active site cleft with maximum stability achieved in the ternary complex containing Mg x ATP and the peptide inhibitor. In this ternary complex the gamma-phosphate is secured between both lobes by hydrogen bonds to the backbone amide of Ser 53 in the glycine-rich loop and the amino group of Lys 168 in the catalytic loop. In the adenosine ternary complex the water molecule replacing the gamma-phosphate hydrogen bonds between Lys 168 and Asp 166 and makes no contact with the small lobe. This glycine-rich loop is thus the most mobile component of the active site cleft, with the tip of the loop being highly sensitive to what occupies the gamma-subsite.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109651     DOI: 10.1021/bi961947+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

1.  Phosphorylation-dependent changes in structure and dynamics in ERK2 detected by SDSL and EPR.

Authors:  Andrew N Hoofnagle; James W Stoner; Thomas Lee; Sandra S Eaton; Natalie G Ahn
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

2.  TRAF family proteins link PKR with NF-kappa B activation.

Authors:  Jesús Gil; Maria Angel García; Paulino Gomez-Puertas; Susana Guerra; Joaquín Rullas; Hiroyasu Nakano; José Alcamí; Mariano Esteban
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

3.  Rapid large-scale purification of myofilament proteins using a cleavable His6-tag.

Authors:  Mengjie Zhang; Jody L Martin; Mohit Kumar; Ramzi J Khairallah; Pieter P de Tombe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

4.  The Scaffold Protein Axin Promotes Signaling Specificity within the Wnt Pathway by Suppressing Competing Kinase Reactions.

Authors:  Maire Gavagan; Erin Fagnan; Elizabeth B Speltz; Jesse G Zalatan
Journal:  Cell Syst       Date:  2020-06-17       Impact factor: 10.304

5.  A-kinase-interacting protein localizes protein kinase A in the nucleus.

Authors:  Mira Sastri; David M Barraclough; Peter T Carmichael; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-03       Impact factor: 11.205

Review 6.  Protein kinases: evolution of dynamic regulatory proteins.

Authors:  Susan S Taylor; Alexandr P Kornev
Journal:  Trends Biochem Sci       Date:  2010-10-23       Impact factor: 13.807

7.  Allosteric cooperativity in protein kinase A.

Authors:  Larry R Masterson; Alessandro Mascioni; Nathaniel J Traaseth; Susan S Taylor; Gianluigi Veglia
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

8.  Expression and biochemical characterization of the Plasmodium falciparum protein kinase A catalytic subunit.

Authors:  Nathalie Wurtz; Boris Pastorino; Lionel Almeras; Sébastien Briolant; Claude Villard; Daniel Parzy
Journal:  Parasitol Res       Date:  2009-01-22       Impact factor: 2.289

9.  Expression and structural characterization of peripherin/RDS, a membrane protein implicated in photoreceptor outer segment morphology.

Authors:  Werner Louwrens Vos; Sebastian Vaughan; Patrick Y Lall; John G McCaffrey; Monika Wysocka-Kapcinska; John B C Findlay
Journal:  Eur Biophys J       Date:  2009-11-18       Impact factor: 1.733

10.  Docking flexible peptide to flexible protein by molecular dynamics using two implicit-solvent models: an evaluation in protein kinase and phosphatase systems.

Authors:  Zunnan Huang; Chung F Wong
Journal:  J Phys Chem B       Date:  2009-10-29       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.